In this episode, Greg and Rob discuss a recent publication regarding how 340B Program participation may impact the degree of biosimilar utilization. Additionally, the guys recap recent legislative proposals with 340B impact that were advanced by the House Energy & Commerce Committee.
Article citation: Health Affairs 42, NO. 5 (2023): 632–641
Version: 20241125